Login or Sign Up
15:59 Feb 25
Alivus Life Sciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Alivus Life Sciences Ltd. Corporate Actions
Alivus Life Sciences Ltd.
Industry Pharmaceuticals
15:59 Feb 25
Quality
57/100
High Financial Strength
Valuation
40/100
Mid Valuation
Technical
36/100
Technically Neutral
Strength
8
Weakness
6
Opportunity
0
Threats
0
0.55 %
Dividend Yield
11.14K
Market Cap (Cr)
RSI
74.91 %
Promoter Holding
0.00 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|---|---|---|---|---|
| 01-Sep-2025 | Dividend | 5.00/share@250.00% | 01-Sep-2025 | 250.00 | Final |
| 17-Oct-2023 | Dividend | 22.50/share@1,125.00% | 17-Oct-2023 | 1,125.00 | Interim |
| 24-Mar-2023 | Dividend | 21.00/share@1,050.00% | 24-Mar-2023 | 1,050.00 | Interim |
| 15-Sep-2022 | Dividend | 10.50/share@525.00% | - | 525.00 | Final |
| 22-Nov-2021 | Dividend | 10.50/share@525.00% | 23-Nov-2021 | 525.00 | Interim |
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully